Targeting Bacterial Biofilms on Medical Implants: Current and Emerging Approaches
Antibiotics · 06.08.2025 · 14 (8) · 802
DOI: 10.3390/antibiotics14080802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 06.08.2025. Verfasst von Alessandro Calogero Scalia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Center for Translational Research on Autoimmune & Allergic Diseases, CAAD, University of Piemonte Orientale, Corso Tri…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Biofilms are structured communities of microorganisms encased in a self-produced extracellular matrix, and they represent one of the most widespread forms of microbial life on Earth. Their presence poses serious challenges in both environmental and clinical settings. In natural and industrial systems, biofilms contribute to water contamination, pipeline corrosion, and biofouling. Clinically, biofilm-associated infections are responsible for approximately 80% of all microbial infections, including endocarditis, osteomyelitis, cystic fibrosis, and chronic sinusitis. A particularly critical concern is their colonization of medical devices, where biofilms can lead to chronic infections, implant failure, and increased mortality. Implantable devices, such as orthopedic implants, cardiac pacemakers, cochlear implants, urinary catheters, and hernia meshes, are highly susceptible to microbial attachment and biofilm development. These infections are often recalcitrant to conventional antibiotics and frequently necessitate surgical revision. In the United States, over 500,000 biofilm-related implant infections occur annually, with prosthetic joint infections alone projected to incur revision surgery costs exceeding USD 500 million per year—a figure expected to rise to USD 1.62 billion by 2030. To address these challenges, surface modification of medical devices has emerged as a promising strategy to prevent bacterial adhesion and biofilm formation. This review focuses on recent advances in chemical surface functionalization using non-antibiotic agents, such as enzymes, chelating agents, quorum sensing quenching factors, biosurfactants, oxidizing compounds and nanoparticles, designed to enhance antifouling and mature biofilm eradication properties. These approaches aim not only to prevent device-associated infections but also to reduce dependence on antibiotics and mitigate the development of antimicrobial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, Center for Translational Research on Autoimmune & Allergic Diseases, CAAD, University of Piemonte Orientale, Corso Trieste 15/A, 28100 Novara, Italy.
ORCID-Profile: Alessandro Calogero Scalia, Ziba Najmi
Zitieren
APA
Scalia, A. C., & Najmi, Z. (2025). Targeting Bacterial Biofilms on Medical Implants: Current and Emerging Approaches. Antibiotics, 14(8), 802. https://doi.org/10.3390/antibiotics14080802
Vancouver
Scalia AC, Najmi Z. Targeting Bacterial Biofilms on Medical Implants: Current and Emerging Approaches. Antibiotics. 2025;14(8):802. doi:10.3390/antibiotics14080802
BibTeX
@article{Scalia2025,
author = {Scalia, Alessandro Calogero and Najmi, Ziba},
title = {Targeting Bacterial Biofilms on Medical Implants: Current and Emerging Approaches},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {8},
pages = {802},
doi = {10.3390/antibiotics14080802}
}
EUVIMED